Review— adidas Adizero Boston 10
Product— adidas Adizero Boston 10
Release Date— Wednesday 17th June 2021
Reviewer— Patrick Monti | @patrickupthere
With adidas’s new direction for their speciality run offering a substantial departure from anything seen in the past, it would be remiss of us to talk about the Boston 10 without touching on its predecessor the Boston 9. A tried and tested lightweight, versatile shoe, the Boston 9 has long been favoured for road racing and fast workouts on-road and the track. Given the current landscape of stack heights, plates of every kind and copious amounts of foam, the Boston 9 would be considered by most like a classic distance flat…enter the Boston 10.
Whilst still placing itself firmly in the fast training category of your shoe roster, you would be misguided in thinking that this Boston is still your go-to distance flat; with the new iteration consisting of similar amounts of foam to that of your average marathon shoe. Comprising of a layer of both Lightstrike, adidas’s EVA foam, and their premium Pebax/EVA offering, Lightstrike Pro. With a 39mm stack height and 8mm drop, the Boston 10 offers a much firmer and in turn more stable ride. Moving away from the plush cushioning often seen in higher stack training shoes. Sandwiched between the layers of foam is a carbon heel plate and adidas’s signature carbon-infused ‘Energy Rods’, shaped to mimic the bone structure of the foot. The outer sole includes Continental rubber, something used before on a number of previous adidas models; but still a substantial inclusion. Offering superior traction across varying surfaces.
Aesthetically, the Boston 10 ticks a lot of boxes. Taking a lot of design queues from the new Adizero Adios Pro 2, but featuring a slightly more substantial upper with the inclusion of a solid heel counter and padded tongue providing excellent lockdown; as well as some suede overlays around the toe box, a heritage throwback perhaps? The extra reinforcement on the upper makes the shoe feel capable of taking some punishment…no need to be precious with this one.
All views shared are that of the author, they have not commercially or financially benefitted from saying one thing or another.